Kimia Farma Persero Tbk - Asset Resilience Ratio
Kimia Farma Persero Tbk (KAEF) has an Asset Resilience Ratio of 0.50% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Kimia Farma Persero Tbk's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2025)
This chart shows how Kimia Farma Persero Tbk's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Kimia Farma Persero Tbk balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down Kimia Farma Persero Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore KAEF strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp70.37 Billion | 0.5% |
| Short-term Investments | Rp0.00 | 0% |
| Total Liquid Assets | Rp70.37 Billion | 0.50% |
Asset Resilience Insights
- Limited Liquidity: Kimia Farma Persero Tbk maintains only 0.50% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Kimia Farma Persero Tbk Industry Peers by Asset Resilience Ratio
Compare Kimia Farma Persero Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332 |
Medical Distribution | 0.00% |
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998 |
Medical Distribution | 0.08% |
Annual Asset Resilience Ratio for Kimia Farma Persero Tbk (2002–2025)
The table below shows the annual Asset Resilience Ratio data for Kimia Farma Persero Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.50% | Rp70.37 Billion ≈ $4.12 Million |
Rp14.18 Trillion ≈ $831.08 Million |
-0.03pp |
| 2024-12-31 | 0.53% | Rp78.87 Billion ≈ $4.62 Million |
Rp14.97 Trillion ≈ $877.01 Million |
+0.37pp |
| 2023-12-31 | 0.15% | Rp27.15 Billion ≈ $1.59 Million |
Rp17.59 Trillion ≈ $1.03 Billion |
+5.48pp |
| 2022-12-31 | -5.33% | Rp-1.08 Trillion ≈ $-63.52 Million |
Rp20.35 Trillion ≈ $1.19 Billion |
+0.81pp |
| 2021-12-31 | -6.13% | Rp-1.09 Trillion ≈ $-63.82 Million |
Rp17.76 Trillion ≈ $1.04 Billion |
+0.82pp |
| 2020-12-31 | -6.95% | Rp-1.22 Trillion ≈ $-71.57 Million |
Rp17.56 Trillion ≈ $1.03 Billion |
-0.06pp |
| 2019-12-31 | -6.89% | Rp-1.26 Trillion ≈ $-74.11 Million |
Rp18.35 Trillion ≈ $1.08 Billion |
+4.79pp |
| 2018-12-31 | -11.68% | Rp-1.11 Trillion ≈ $-64.75 Million |
Rp9.46 Trillion ≈ $554.34 Million |
-21.65pp |
| 2017-12-31 | 9.97% | Rp607.94 Billion ≈ $35.62 Million |
Rp6.10 Trillion ≈ $357.21 Million |
+20.76pp |
| 2016-12-31 | -10.79% | Rp-497.60 Billion ≈ $-29.16 Million |
Rp4.61 Trillion ≈ $270.28 Million |
-5.11pp |
| 2015-12-31 | -5.68% | Rp-183.75 Billion ≈ $-10.77 Million |
Rp3.24 Trillion ≈ $189.63 Million |
-0.78pp |
| 2014-12-31 | -4.90% | Rp-145.49 Billion ≈ $-8.53 Million |
Rp2.97 Trillion ≈ $173.92 Million |
-0.44pp |
| 2013-12-31 | -4.46% | Rp-110.30 Billion ≈ $-6.46 Million |
Rp2.47 Trillion ≈ $144.85 Million |
-1.09pp |
| 2012-12-31 | -3.37% | Rp-70.02 Billion ≈ $-4.10 Million |
Rp2.08 Trillion ≈ $121.67 Million |
-3.71pp |
| 2004-12-31 | 0.34% | Rp4.00 Billion ≈ $234.38K |
Rp1.17 Trillion ≈ $68.76 Million |
-5.89pp |
| 2003-12-31 | 6.23% | Rp85.11 Billion ≈ $4.99 Million |
Rp1.37 Trillion ≈ $80.09 Million |
+3.54pp |
| 2002-12-31 | 2.68% | Rp27.86 Billion ≈ $1.63 Million |
Rp1.04 Trillion ≈ $60.85 Million |
-- |
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrup… Read more